In the PI-RADS 3 population (n = 121), MiPS showed the best clinical performance for predicting GG ≥ 2 cancer with an AUC of 0.73 compared to AUCs of 0.55 for PSA and 0.62 for PSA density. The gene discussed is KLK3; the disease is cancer.